Drug Safety Pharmacovigilance
1. Patient 2. Event 3. Reporter
Patient Initials*
Age / Date of Birth*
Gender* SelectMaleFemaleOther
Product Name*
Batch / Lot Number
Event Start Date*
Description of Symptoms*
Reporter Name*
Phone Number*
Email Address*
I consent to the processing of personal data and agree with the user agreement and privacy policy
Showing the single result
Therapeutic Segment: Anti-Emetic Generic Name: Ondansetron Available as: Tablet 4mg Tablet 8mg Orodispersible Tablet 8mg Syrup 4mg/5mL Injection 4mg/2mL Injection